Mycobacterium tuberculosis - Still the Greatest Microbial Challenge in the World

1999 ◽  
Vol 10 (3) ◽  
pp. 133-133
2017 ◽  
Vol 7 (2) ◽  
pp. 86-89 ◽  
Author(s):  
Nourjahan Laskar ◽  
Md Akram Hossain ◽  
Jannatul Fardows ◽  
Mominur Rahman

Background: The World Health Organization has endorsed the use of molecular methods for the detection of tuberculosis (TB) and drug resistant TB as a rapid method. In Bangladesh, the Xpert MTB/RIF assay has been implemented into reference laboratories for diagnosis of TB and also MDR TB.Objective: Drug resistant tuberculosis has long been a common problem prevailing in our country. The present study focused on the rapid identification of Mycobacterium tuberculosis as well as drug resistance.Materials and Methods: Sputum samples from a total of 107 cases, assumed as multi-drug resistance tuberculosis, were studied through GeneXpert assay.Results: Out of 107 cases, 91 (85.05%) were detected having M. tuberculosis ? 64 (59.81%) were rifampicin sensitive and 27 (25.23%) were rifampicin resistant. The sensitivity and specificity of the GeneXpert are 87.64% and 75% respectively.Conclusion: GeneXpert assay can be considered for the rapid diagnosis of drug resistant tuberculosis.J Enam Med Col 2017; 7(2): 86-89


2020 ◽  
Vol 10 (7) ◽  
pp. 2632 ◽  
Author(s):  
Carlos Martin ◽  
Nacho Aguilo ◽  
Dessislava Marinova ◽  
Jesus Gonzalo-Asensio

In addition to antibiotics, vaccination is considered among the most efficacious methods in the control and the potential eradication of infectious diseases. New safe and effective vaccines against tuberculosis (TB) could be a very important tool and are called to play a significant role in the fight against TB resistant to antimicrobials. Despite the extended use of the current TB vaccine Bacillus Calmette-Guérin (BCG), TB continues to be transmitted actively and continues to be one of the 10 most important causes of death in the world. In the last 20 years, different TB vaccines have entered clinical trials. In this paper, we review the current use of BCG and the diversity of vaccines in clinical trials and their possible indications. New TB vaccines capable of protecting against respiratory forms of the disease caused by sensitive or resistant Mycobacterium tuberculosis strains would be extremely useful tools helping to prevent the emergence of multi-drug resistance.


2017 ◽  
Vol 107 (6) ◽  
pp. 466 ◽  
Author(s):  
Nesri Padayatchi ◽  
Sharana Mahomed ◽  
Max O’Donnell ◽  
Francesca Conradie ◽  
Kogieleum Naidoo

2011 ◽  
Vol 2011 ◽  
pp. 1-13 ◽  
Author(s):  
Luisa Jordao ◽  
Otilia V. Vieira

Tuberculosis is an ancient infectious disease that remains a threat for public health around the world. Although the etiological agent as well as tuberculosis pathogenesis is well known, the molecular mechanisms underlying the host defense to the bacilli remain elusive. In this paper we focus on the innate immunity of this disease reviewing well-established and consensual mechanisms likeMycobacterium tuberculosisinterference with phagosome maturation, less consensual mechanism like nitric oxide production, and new mechanisms, such as mycobacteria translocation to the cytosol, autophagy, and apoptosis/necrosis proposed mainly during the last decade.


2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Carlos Rodrigo Zárate-Bladés ◽  
Celio Lopes Silva ◽  
Geraldo A. Passos

In 1882 Robert Koch identifiedMycobacterium tuberculosisas the causative agent of tuberculosis (TB), a disease as ancient as humanity. Although there has been more than 125 years of scientific effort aimed at understanding the disease, serious problems in TB persist that contribute to the estimated 1/3 of the world population infected with this pathogen. Nonetheless, during the first decade of the 21st century, there were new advances in the fight against TB. The development of high-throughput technologies is one of the major contributors to this advance, because it allows for a global vision of the biological phenomenon. This paper analyzes how transcriptomics are supporting the translation of basic research into therapies by resolving three key issues in the fight against TB: (a) the discovery of biomarkers, (b) the explanation of the variability of protection conferred by BCG vaccination, and (c) the development of new immunotherapeutic strategies to treat TB.


2015 ◽  
Vol 212 (11) ◽  
pp. 1759-1769 ◽  
Author(s):  
Jennifer L. Gardiner ◽  
Christopher L. Karp

The world is in need of more effective approaches to controlling tuberculosis. The development of improved control strategies has been hampered by deficiencies in the tools available for detecting Mycobacterium tuberculosis and defining the dynamic consequences of the interaction of M. tuberculosis with its human host. Key needs include a highly sensitive, specific nonsputum diagnostic; biomarkers predictive of responses to therapy; correlates of risk for disease development; and host response–independent markers of M. tuberculosis infection. Tools able to sensitively detect and quantify total body M. tuberculosis burden might well be transformative across many needed use cases. Here, we review the current state of the field, paying particular attention to needed changes in experimental paradigms that would facilitate the discovery, validation, and development of such tools.


2018 ◽  
Vol 2 (2) ◽  
pp. 77-92
Author(s):  
Tsuraya Mumtaz ◽  
Agung Priyo Utomo

Tuberculosis (TB) is an infectious disease caused by Mycobacterium Tuberculosis. Untill now, TB is still one of the main problems in many countries, especially developing countries. Indonesia ranked second as the country with the highest TB cases in the world in 2015, where most cases were found in Java. This study was conducted to model the number of new pulmonary TB cases in Java by considering the spatial aspects using Geographically Weighted Negative Binomial Regression (GWNBR). GWNBR method was chosen  because the data used in this study are overdispered. The result showed that the population density and percentage of healty homes were not significantly influential in each region. While the number of puskesmas, the percentage of smokers, the percentage of good PHBS, the percentage of diabetes mellitus, and the percentage of less IMT were significant in some regions. In general, the GWNBR model was better for modelling the number of new pulmonary TB cases than negative binomial regression and GWPR.


Sign in / Sign up

Export Citation Format

Share Document